# Assessment of Intracerebral Hematoma

Study · id `cardio:ct-nct05158660` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05158660](<https://clinicaltrials.gov/study/NCT05158660>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05158660

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT05158660. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-01 (anticipated); primary completion 2022-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT05158660, source copy `cardio:ctgov-nct05158660-2021-12-15`, retrieved 2026-10-31)
- Planned start: 2022-01 (anticipated) (ClinicalTrials.gov record NCT05158660, source copy `cardio:ctgov-nct05158660-2021-12-15`, retrieved 2026-10-31)
- Primary completion: 2022-10 (anticipated) (ClinicalTrials.gov record NCT05158660, source copy `cardio:ctgov-nct05158660-2021-12-15`, retrieved 2026-10-31)
- Completion: 2023-01 (anticipated) (ClinicalTrials.gov record NCT05158660, source copy `cardio:ctgov-nct05158660-2021-12-15`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05158660-2021-12-15`, retrieved 2026-10-31)

## The registry's words

- Brief title: Assessment of Intracerebral Hematoma
- Condition: Intracerebral Hematoma
- Intervention (Device): transcranial duplex sonography
- Lead sponsor: Assiut University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry lists this organization as the lead sponsor: Assiut University (`cardio:org-assiut-university`)

## Provenance

Content hash: 468dbbdd34df91faa6e92d89eeb0be8a973a6606380e3474111509d2792eb2db
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
